RxNorm Semantic Concepts Index - 190
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "190".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 190 | 1 biotinyl-CoA synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 190 | 1 biotinyl-CoA synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 190 | 1 biotinyl-CoA synthetase | Designated preferred name (PT) | NO | |
| RxCUI: 190 | 1 biotinyl-CoA synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 190 | 1 biotinyl-CoA synthetase | Full form of descriptor (FN) | NO | |
| RxCUI: 190 | 1 biotinyl-CoA synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 190 | 1 biotinyl-CoA synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 190 | 1 biotinyl-CoA synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1900396 | Scopolia | Designated preferred name (PT) | NO | |
| RxCUI: 1900396 | Scopolia | Full form of descriptor (FN) | NO | |
| RxCUI: 19005 | Benzoquinonium | Designated preferred name (PT) | NO | |
| RxCUI: 19005 | Benzoquinonium | Full form of descriptor (FN) | NO | |
| RxCUI: 19008 | Benzthiazide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 19008 | Benzthiazide | Designated preferred name (PT) | NO | |
| RxCUI: 19008 | Benzthiazide | Full form of descriptor (FN) | NO | |
| RxCUI: 19008 | Benzthiazide | Designated preferred name (PT) | NO | |
| RxCUI: 19008 | Benzthiazide | Full form of descriptor (FN) | NO | |
| RxCUI: 190099 | Estratab | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1901 | Calcium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1901 | Calcium chloride | Designated preferred name (PT) | YES | |
| RxCUI: 1901 | Calcium chloride | Full form of descriptor (FN) | YES | |
| RxCUI: 1901 | Calcium chloride | Designated preferred name (PT) | YES | |
| RxCUI: 1901 | Calcium chloride | Full form of descriptor (FN) | YES | |
| RxCUI: 1901516 | Product containing florbetaben (18-F) (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 1901516 | Product containing florbetaben (18-F) (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 19019 | Benzoylecgonine | Designated preferred name (PT) | NO | |
| RxCUI: 19019 | Benzoylecgonine | Full form of descriptor (FN) | NO | |
| RxCUI: 1902 | Calcium carbimide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1902 | Calcium carbimide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1902 | Calcium carbimide | Designated preferred name (PT) | NO | |
| RxCUI: 1902 | Calcium carbimide | Full form of descriptor (FN) | NO | |
| RxCUI: 190283 | Flomax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1903 | Calcium disodium edetate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1903 | Calcium disodium edetate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1903 | Calcium disodium edetate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1903 | Calcium disodium edetate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1903 | Calcium disodium edetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1903 | Calcium disodium edetate | Designated preferred name (PT) | YES | |
| RxCUI: 1903 | Calcium disodium edetate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1903 | Calcium disodium edetate | Full form of descriptor (FN) | YES | |
| RxCUI: 190353 | Daclizumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 190353 | Daclizumab | Designated preferred name (PT) | NO | |
| RxCUI: 190353 | Daclizumab | Full form of descriptor (FN) | NO | |
| RxCUI: 190353 | Daclizumab | Designated preferred name (PT) | NO | |
| RxCUI: 190353 | Daclizumab | Full form of descriptor (FN) | NO | |
| RxCUI: 190376 | linezolid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 190376 | linezolid | Designated preferred name (PT) | YES | |
| RxCUI: 190376 | linezolid | Full form of descriptor (FN) | YES | |
| RxCUI: 190376 | linezolid | Designated preferred name (PT) | YES | |
| RxCUI: 190376 | linezolid | Full form of descriptor (FN) | YES | |
| RxCUI: 1904 | calcium dobesilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 19041 | benzquinamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 19041 | benzquinamide | Designated preferred name (PT) | NO | |
| RxCUI: 19041 | benzquinamide | Full form of descriptor (FN) | NO | |
| RxCUI: 19041 | benzquinamide | Designated preferred name (PT) | NO | |
| RxCUI: 19041 | benzquinamide | Full form of descriptor (FN) | NO | |
| RxCUI: 190410 | flucloronide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 190413 | Beta-lysine mutase | Designated preferred name (PT) | NO | |
| RxCUI: 190413 | Beta-lysine mutase | Full form of descriptor (FN) | NO | |
| RxCUI: 190413 | Beta-lysine mutase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 190433 | pramiverine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 19044 | benzyl benzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 19044 | benzyl benzoate | Designated preferred name (PT) | YES | |
| RxCUI: 19044 | benzyl benzoate | Full form of descriptor (FN) | YES | |
| RxCUI: 19044 | benzyl benzoate | Designated preferred name (PT) | YES | |
| RxCUI: 19044 | benzyl benzoate | Full form of descriptor (FN) | YES | |
| RxCUI: 190465 | Viagra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1905 | calcium fluoride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 190521 | abacavir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 190521 | abacavir | Designated preferred name (PT) | YES | |
| RxCUI: 190521 | abacavir | Full form of descriptor (FN) | YES | |
| RxCUI: 190521 | abacavir | Designated preferred name (PT) | YES | |
| RxCUI: 190521 | abacavir | Full form of descriptor (FN) | YES | |
| RxCUI: 190548 | tipranavir | Full form of descriptor (FN) | YES | |
| RxCUI: 190548 | tipranavir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 190548 | tipranavir | Designated preferred name (PT) | YES | |
| RxCUI: 190548 | tipranavir | Full form of descriptor (FN) | YES | |
| RxCUI: 190548 | tipranavir | Designated preferred name (PT) | YES | |
| RxCUI: 1907 | calcium glucarate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 19075 | benzylparaben | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 190754 | Oregovomab | Designated preferred name (PT) | NO | |
| RxCUI: 190754 | Oregovomab | Full form of descriptor (FN) | NO | |
| RxCUI: 190754 | Oregovomab | Designated preferred name (PT) | NO | |
| RxCUI: 190754 | Oregovomab | Full form of descriptor (FN) | NO | |
| RxCUI: 19079 | Benzylpenicilloyl polylysine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 19079 | Benzylpenicilloyl polylysine | Designated preferred name (PT) | NO | |
| RxCUI: 19079 | Benzylpenicilloyl polylysine | Full form of descriptor (FN) | NO | |
| RxCUI: 19079 | Benzylpenicilloyl polylysine | Designated preferred name (PT) | NO | |
| RxCUI: 19079 | Benzylpenicilloyl polylysine | Full form of descriptor (FN) | NO | |
| RxCUI: 1908 | Calcium gluconate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1908 | Calcium gluconate | Designated preferred name (PT) | YES | |
| RxCUI: 1908 | Calcium gluconate | Full form of descriptor (FN) | YES | |
| RxCUI: 1908 | Calcium gluconate | Designated preferred name (PT) | YES | |
| RxCUI: 1908 | Calcium gluconate | Full form of descriptor (FN) | YES | |
| RxCUI: 1908248 | Product containing roxadustat (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 1908248 | Product containing roxadustat (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 1908248 | Product containing roxadustat (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 1908248 | Product containing roxadustat (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 19084 | benzylthiouracil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 19084 | benzylthiouracil | Designated preferred name (PT) | NO | |
| RxCUI: 19084 | benzylthiouracil | Full form of descriptor (FN) | NO | |
| RxCUI: 190855 | Isobutyryl-coenzyme A mutase | Designated preferred name (PT) | NO | |
| RxCUI: 190855 | Isobutyryl-coenzyme A mutase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 190855 | Isobutyryl-coenzyme A mutase | Full form of descriptor (FN) | NO | |
| RxCUI: 19087 | Bephenium hydroxynaphthoate | Designated preferred name (PT) | NO | |
| RxCUI: 19087 | Bephenium hydroxynaphthoate | Full form of descriptor (FN) | NO | |
| RxCUI: 1908865 | Anti-Human metapneumovirus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1908865 | Anti-Human metapneumovirus IgG | Designated preferred name (PT) | NO | |
| RxCUI: 1908865 | Anti-Human metapneumovirus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1908865 | Anti-Human metapneumovirus IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 1909 | calcium glycerophosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |